Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.

Included Health is launching an alternative health plan centered on primary care, AI support, price transparency and easier navigation.

Hair loss remains an area lacking biotechnology innovation. The drugs currently available are older products offering limited efficacy. Some of them cannot be used by women. Veradermics aims to shake ...

Regeneron Pharmaceuticals is committing $150 million to begin an alliance on a Tessera Therapeutics gene-editing medicine nearing the clinic as a potential treatment for a rare disease that leads to ...

Astellas Pharma is far from alone in viewing cancer as a major growth area, but the Japanese drugmaker has specifically identified a type of therapy called targeted protein degradation as one of the ...

Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it.

As the mental health crisis in the U.S. grows, mental health professionals are increasingly struggling due to workforce shortages. More than half of therapists report having feelings of burnout. And ...

Spend a few minutes with someone in EMS, fire service, or healthcare, and you’ll likely hear some version of the same concerns: call volumes increasing, crews stretched thin, and many of the systems ...

As OpenAI and Anthropic move deeper into healthcare, experts say AI chatbots are becoming the new front door to medicine. This shift is shaking things up for some health tech startups, redefining the ...

Women’s health has been historically sidelined – underfunded, underresearched and often misunderstood. While interest and investment around complex women’s health have increased, we’re still a long ...

Kaiser Permanente announced a significant AI partnership this week aimed at enhancing value-based care. The West Coast-based health system is deploying Innovaccer’s healthcare AI platform and ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...